Consensus IMAX Corporation

Stocks

IMAX

CA45245E1097

Entertainment Production

Market Closed - NYSE 21:00:02 21/10/2026 BST			5-day change	1st Jan Change
53.09 ^USD	+1.24%		+2.77%	+43.64%

10-19	Barrington Raises Price Target on IMAX to $60 From $50, Keeps Outperform Rating	MT
10-14	IMAX Has More to Come After Q3 'Victory' Lap, Wedbush Says	MT

Evolution of the Average Target: IMAX Corporation

Evolution of the Target Price: IMAX Corporation

Changes in Analyst Recommendations: IMAX Corporation

55283516cdfd80bf84c931dd1cd.OvXMDRxGRbG7dv8vIoAH39xa9IIZp6ofMjK4MC59udM.W6ehaWQeGofzQ8xjVbYzjuk8oMNK6dxAQWXcXmsR-54Iw4lJUBV8gs9Azw~4b94c900f7aee394a873c7d5e448d0ee

Analysts' recommendations: IMAX Corporation

10-19	Barrington Raises Price Target on IMAX to $60 From $50, Keeps Outperform Rating	MT
10-14	IMAX Has More to Come After Q3 'Victory' Lap, Wedbush Says	MT
10-14	Wedbush Raises Price Target on IMAX to $60 From $54, Keeps Outperform Rating	MT
10-08	B. Riley Raises Price Target on IMAX to $64 From $61, Keeps Buy Rating	MT
09-24	Morgan Stanley Initiates IMAX at Overweight With $63 Price Target	MT
08-24	B. Riley Adjusts IMAX Price Target to $61 From $52, Maintains Buy Rating	MT
07-24	IMAX Q2 Results Reinforce Long-Term Growth Outlook, Wedbush Says	MT
07-24	Barrington Research Adjusts IMAX Price Target to $50 From $46, Maintains Outperform Rating	MT
07-24	B. Riley Adjusts Price Target on IMAX to $52 From $48, Maintains Buy Rating	MT
07-24	Wedbush Adjusts Price Target on IMAX to $54 From $46, Maintains Outperform Rating	MT
07-16	IMAX's H2 Outlook Remains Strong Despite Modest Q2 Growth, Wedbush Says	MT
07-16	Wells Fargo Downgrades IMAX to Equalweight From Overweight, Cuts Price Target to $41 From $47	MT
07-10	B. Riley Adjusts IMAX Price Target to $48 From $46, Maintains Buy Rating	MT
05-18	IMAX on Track to Reach $1.4 Billion in Box Office Proceeds Despite Headwinds, B. Riley Says	MT
05-04	Barrington Raises Price Target on IMAX to $46 From $42, Keeps Outperform Rating	MT
05-01	IMAX is Poised to Surpass 50% EBITDA Margins by 2028 on Rise in Filmed-for-IMAX Titles, Wedbush Says	MT
04-23	IMAX's Global Film Slate Likely to Support 'Robust' 2026, Wedbush Says	MT
04-17	B. Riley Upgrades 2026 Box Office Outlook Following First-Quarter Beat	MT
02-27	Macquarie Raises Price Target on IMAX to $45 From $44, Keeps Outperform Rating	MT
02-26	IMAX Poised to Benefit from Multiple Factors, Wedbush Says	MT
02-26	B. Riley Adjusts Price Target on IMAX to $46 From $44, Maintains Buy Rating	MT
12-15	JPMorgan Upgrades IMAX to Overweight From Neutral, Adjusts Price Target to $47 From $32	MT
12-08	IMAX EBITDA Margins Seen Surpassing 50% by 2028, Wedbush Says	MT
12-08	Wedbush Raises Price Target on IMAX to $46 From $39, Keeps Outperform Rating	MT
12-08	Barrington Raises Price Target on IMAX to $42 From $37, Keeps Outperform Rating	MT

More recommendations

Other Entertainment Production

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	IMAX CORPORATION					+12.83%
	LIVE NATION ENTERTAINMENT, INC.					+15.92%
	SKYDANCE CORPORATION					+26.88%
	UNIVERSAL MUSIC GROUP N.V.					+33.81%
	ROKU, INC.					+3.02%
	WARNER MUSIC GROUP CORP.					+21.29%
	BOLLORÉ SE					+15.1%
	MADISON SQUARE GARDEN SPORTS CORP.					+16.27%
	TOHO CO., LTD.					+3.74%
	MANGO EXCELLENT MEDIA CO., LTD.					-14.13%
	Average					+13.47%
	Weighted average by Cap.					+18.26%